TransMedics Group, Inc.
TMDXTransMedics Group is a medical technology company that has developed a paradigm-shifting platform for organ transplantation.
Earnings
Next report
Aug 4, 2026 (In 6 days)Revenue estimate$183.8M
EPS estimate$0.50
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
TransMedics Group is a medical technology company that has developed a paradigm-shifting platform for organ transplantation. Its proprietary Organ Care System (OCS) replaces traditional cold storage by maintaining donor organs in a living, functioning state through warm, oxygenated perfusion. The company also provides a comprehensive National OCS Program (NOP) that offers turnkey organ procurement and logistics services, including a dedicated aviation fleet.
Competitive position
The company holds a unique market position as the provider of the only FDA-approved, portable, multi-organ, warm perfusion technology platform.
GeographiesUnited States, Europe, Canada, Asia-Pacific
Customer segmentsHospitals, Transplant Centers, Government Healthcare Programs
Business modelRazor-and-blade, Service-as-a-Product, Direct Sales
SuppliersComponent manufacturers, Single-source solution suppliers, Sterilization service providers, Aircraft manufacturers, Blood supply for perfusion
CustomersTransplant surgeons, Hospitals, Medicare/Medicaid, Private insurance payors
CountryUnited States of America
Listed2019
Employees584.0
CEOWaleed H. Hassanein
SectorHealthcare
IndustryMedical - Devices
Websitetransmedics.com
FilingsSEC EDGAR
Questions, answered.
- What is TransMedics Group, Inc.'s market cap?
- TransMedics Group, Inc. (TMDX) has a market capitalization of $2.6B and trades on NASDAQ.
- What is TransMedics Group, Inc.'s revenue and profitability?
- TransMedics Group, Inc. generated $635.9M in trailing twelve-month revenue with net income of $171.9M, representing a net margin of 27.0%. Gross margin stands at 59.1%, with free cash flow of $151.4M. These figures are based on the Q1 2026 filing.
- Who are TransMedics Group, Inc.'s competitors?
- TransMedics Group, Inc.'s key competitors include Cytosorbents Corp., Strata Critical Medical, Inc. Class A Common Stock, CareDx, Inc., and others. These companies compete in similar markets and product categories.
- Who does TransMedics Group, Inc. partner with?
- TransMedics Group, Inc.'s notable partners include Fresenius.
- What subsidiaries does TransMedics Group, Inc. have?
- TransMedics Group, Inc.'s subsidiaries include TransMedics, Inc., Summit Aviation, Inc., Northside Property Group, LLC.
- Where is TransMedics Group, Inc. headquartered?
- TransMedics Group, Inc. is headquartered in United States of America and employs approximately 584 people. It has been publicly traded since 2019.
